S.N. Parsons, S.D. Luzio, D.R. Owens, SMBG Study Group. Using structured self-monitoring of blood glucose to improve diabetes knowledge: the SMBG study. 54th EASD Annual Meeting, 2018
David R. Owens, Wolfgang Landgraf, Mei Zhang, Brian M. Frier, Luigi Meneghini, Philip Home, Geremia B. Bolli. High Levels of Baseline HbA1c, FPG, and 2-Hour Postprandial Glucose Are Key Predictors for Not Achieving HbA1c < 7.0% at Six Months in People with T2DM Starting Insulin Glargine 100 U/mL. American Diabetes Association 78th Scientific Sessions, 2018.
Alistair N. Lumb, Ian W. Gallen, Alex Bickerton, Ralph R. Abraham, Stephen C. Bain, Roy Harper, Robert E. Ryder, Abcd Nationwide Degludec Audit Contributors. Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit. American Diabetes Association 78th Scientific Sessions, 2018.
Danny Sugimoto, Juan P. Frias, Didier Gouet, Róbert Takács, Ting Jia, Petra Örsy, Stephen C. Bain. Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program. American Diabetes Association 78th Scientific Sessions, 2018.
Julio Rosenstock, Louis B. Chaykin, Joerg Luedemann, Sten Madsbad, Sr., Julie F. Larsen, Emre Yildirim, Stephen C. Bain. Consistent HbA1c and Body Weight Reduction with Semaglutide Independent of Diabetes Duration—SUSTAIN 1-5 and 7 Patient-Level Meta-analysis. American Diabetes Association 78th Scientific Sessions, 2018.
Cornelis Tack, Stephan Jacob, Cyrus Desouza, Stephen C. Bain, Michael A. Nauck, John Petrie, Neil R. Poulter, Richard E. Pratley, Helen Vanya Biering Kjaer Stegmann, Heidrun Bosch-Traberg, Elena Startseva, Bernard Zinman, Leader Publication Committee & Investigators. Liraglutide Effects in Insulin-Treated Patients in LEADER. American Diabetes Association 78th Scientific Sessions, 2018.
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter A. Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Fredrik A. Thoren, Anna Maria Langkilde, On Behalf Of The Depict-2 Investigators. Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study. American Diabetes Association 78th Scientific Sessions, 2018.
David Owens, Rebecca Thomas, Jane Lewis, Miriam Evans, Martin Woodcok, Alexandra McCabe, Steve Chave, Robert Malbon, Keith Harding, Scott Cawley, Roselyn Thomas, Elizabeth Mudge, Rhys Thomas, Leslie Lowe, Anne Hutchings, Priam Saddul, Nalisha Manroe, Ronnie Bohla, Miguel Pinto, Jorge Calderon. Supporting the establishment of diabetes care services in Mauritius, Trinidad and Peru Innovations in Medicine 2018: Royal College of Physicians Annual Conference
S.N. Parsons, S.D. Luzio, D.R. Owens, SMBG Study Group. The SMBG Study: Structured Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. IDF Congress 2017
R.L. Thomas, F.D. Dunstan, S.D. Luzio, R. Peter, D.R. Owens. Is biennial screening safe for people with type 1 diabetes without evidence of diabetic retinopathy. IDF Congress 2017